The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer
Official Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer
Study ID: NCT00306137
Brief Summary: Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Atlanta, Georgia, United States
, Augusta, Georgia, United States
, Indianapolis, Indiana, United States
, Indianapolis, Indiana, United States
, Boston, Massachusetts, United States
, St. Louis, Missouri, United States
, Durham, North Carolina, United States
, Cleveland, Ohio, United States
, Pittsburgh, Pennsylvania, United States
, Houston, Texas, United States
, Salt Lake City, Utah, United States
, Charlottesville, Virginia, United States
, ask Contact, , Australia
, ask Contact, , Austria
, ask Contact, , Belgium
, ask Contact, , Canada
, ask Contact, , Denmark
, ask Contact, , France
, ask Contact, , Germany
, ask Contact, , Spain
, ask Contact, , United Kingdom
Name: Bayer Study Director
Affiliation: Bayer
Role: STUDY_DIRECTOR